Assessing treatment-resistant posttraumatic stress disorder: The emory treatment resistance interview for PTSD (E-TRIP)

Behavioral Sciences

Volumn 4, Issue 4, 2014, Pages 511-527

  Dunlop, Boadie W ^a   Kaye, Joanna L ^a,b   Youngner, Cole ^c   Rothbaum, Barbara ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^c EMORY UNIVERSITY   (United States)

Author keywords

Antidepressive agents; Evidence based medicine; Psychiatric status rating scales; Psychotherapy; Treatment failure; Treatment outcomes

Indexed keywords

EID: 84977066296     PISSN: None     EISSN: 2076328X     Source Type: Journal    
DOI: 10.3390/bs4040511     Document Type: Article

References (77)

1. Rodriguez, P.; Holowka, D.W.; Marx, B.P. Assessment of posttraumatic stress disorder-related functional impairment: A review. J. Rehabil. Res. Dev. 2012, 49, 649–666.
2. Katz, C.; Stein, M.; Richardson, J.D.; Seedat, S.; Sareen, J. A review of interventions for treatment-resistant posttraumatic stress disorder. In Different Views of Anxiety Disorders; Selek, S., Ed.; InTech: Rijeka, Croatia, 2011; pp. 251–270.
3. Forbes, D.; Creamer, M.; Bisson, J.I.; Cohen, J.A.; Chow, B.E.; Foa, E.B.; Friedman, M.J.; Keane, T.M.; Kudler, H.S.; Ursano, R.J. A guide to guidelines for the treatment of PTSD and related conditions. J. Trauma. Stress 2010, 23, 537–552, doi:10.1002/jts.20565.
4. Foa, E.B.; Keane, T.M.; Friedman, M.J.; Cohen, J.A. Effective Treatments for PTSD: Practice Guidelines from the International Society for Traumatic Stress Studies, 2nd ed.; Guilford: New York, NY, USA, 2008.
5. Lachin, J.M. Statistical considerations in the intent-to-treat principle. Control. Clin. Trials 2000, 21, 167–189, doi: 10.1016/S0197-2456(00)00046-5.
6. Blake, D.D.; Weathers, F.W.; Nagy, L.M.; Kaloupek, D.G.; Gusman, F.D.; Charney, D.S.; Keane, T.M. The development of a clinician-administered PTSD scale. J. Trauma. Stress 1995, 8, 75–90.
7. Schnurr, P.P.; Friedman, M.J.; Foy, D.W.; Shea, M.T.; Hsieh, F.Y.; Lavori, P.W.; Glynn, S.M.; Wattenberg, M.; Bernardy, N.C. Randomized trial of trauma-focused group therapy for posttraumatic stress disorder: Results from a Department of Veterans Affairs cooperative study. Arch. Gen. Psychiatry 2003, 60, 481–489, doi:10.1001/archpsyc.60.5.481.
8. Davidson, J.R.; Book, S.W.; Colket, J.T.; Tupler, L.A.; Roth, S.; David, D.; Hertzberg, M.; Mellman, T.; Beckham, J.C.; Smith, R.D. Assessment of a new self-rating scale for post-traumatic stress disorder. Psychol. Med. 1997, 27, 153–160, doi:10.1017/S0033291796004229.
9. Weiss, D.S.; Marmar, C.R. The Impact of Event Scale Revised. In Assessing Psychological Trauma and PTSD–A Practitioners Handbook; Wilson, J.P., Keane, T.M., Eds.; Guilford Press: New York, NY, USA, 1997; pp. 168–169.
10. Blanchard, E.B.; Jones-Alexander, J.; Buckley, T.C.; Forneris, C.A. Psychometric properties of the PTSD Checklist (PCL). Behav. Res. Ther. 1996, 34, 669–673, doi:10.1016/0005-7967(96)00033-2.
11. Foa, E.B.; Cashman, L.; Jaycox, L.; Perry, K. The validation of a self-report measure of posttraumatic stress disorder: the Posttraumatic Diagnostic Scale. Psychol. Assess. 1997, 9, 445–451, doi:10.1037/1040-3590.9.4.445.
12. Foa, E.B.; Riggs, D.S.; Dancu, C.V.; Rothbaum, B.O. Reliability and validity of a brief instrument for assessing post-traumatic stress disorder. J. Trauma. Stress 1993, 6, 459–473, doi:10.1002/jts.2490060405.
13. Fava, M. Diagnosis and definition of treatment-resistant depression. Biol. Psychiatry 2003, 53, 649–659, doi:10.1016/S0006-3223(03)00231-2.
14. Fekadu, A.; Wooderson, S.; Donaldson, C.; Markopoulou, K.; Masterson, B.; Poon, L.; Cleare, A.J. A multidimensional tool to quantify treatment resistance in depression: The Maudsley staging method. J. Clin. Psychiatry 2009, 70, 177–184, doi:10.4088/JCP.08m04309.
15. Australian Centre for Posttraumatic Mental Health (ACPMH). Australian Guidelines for the Treatment of Adults with Acute Stress Disorder and Posttraumatic Stress Disorder; ACPMH: Melbourne, Australia, 2007.
16. Friedman, M.J. Current and future drug treatment for posttraumatic stress disorder patients. Psychiatr. Ann. 1998, 28, 461–468.
17. Martenyi, F.; Brown, E.B.; Zhang, H.; Koke, S.C.; Prakash, A. Fluoxetine v. placebo in prevention of relapse in post-traumatic stress disorder. Br. J. Psychiatry 2002, 181, 315–320, doi:10.1192/bjp.181.4.315.
18. Pollack, M.H.; Hoge, E.A.; Worthington, J.J.; Moshier, S.J.; Wechsler, R.S.; Brandes, M.; Simon, N.M. Eszopiclone for the treatment of posttraumatic stress disorder and associated insomnia: A randomized, double-blind, placebo-controlled trial. J. Clin. Psychiatry 2011, 72, 892–897, doi:10.4088/JCP.09m05607gry.
19. Raskind, M.A.; Peterson, K.; Williams, T.; Hoff, D.J.; Hart, K.; Holmes, H.; Homas, D.; Hill, J.; Daniels, C.; Calohan, J. A trial of prazosin for combat trauma PTSD with nightmares in active-duty soldiers returned from Iraq and Afghanistan. Am. J. Psychiatry 2013, 170, 1003–1010, doi:10.1176/appi.ajp.2013.12081133.
20. Benedek, D.M.; Friedman, M.J.; Zatzick, D.; Ursano, R.J. Guideline Watch (March 2009): Practice Guideline for the Treatment of Patients with Acute Stress Disorder and Posttraumatic Stress Disorder; American Psychiatric Association: Arlington, MA, USA, 2009.
21. Davidson, J.R.; Rothbaum, B.O.; van der Kolk, B.A.; Sikes, C.R.; Farfel, G.M. Multicenter, double-blind comparison of sertraline and placebo in the treatment of posttraumatic stress disorder. Arch. Gen. Psychiatry 2001, 58, 485–492, doi:10.1001/archpsyc.58.5.485.
22. Davidson, J.; Rothbaum, B.O.; Tucker, P.; Asnis, G.; Benattia, I.; Musgnung, J.J. Venlafaxine extended release in posttraumatic stress disorder: A sertraline-and placebo-controlled study. J. Clin. Psychopharmacol. 2006, 26, 259–267, doi:10.1097/01.jcp.0000222514.71390.c1.
23. Glenn, D.; Golinelli, D.; Rose, R.D.; Roy-Byrne, P.; Stein, M.B.; Sullivan, G.; Bystritksy, A.; Sherbourne, C.; Craske, M.G. Who gets the most out of cognitive behavioral therapy for anxiety disorders? The role of treatment dose and patient engagement. J. Consult. Clin. Psychol. 2013, 81, 639–649, doi:10.1037/a0033403.
24. Foa, E.B.; Yusko, D.A.; McLean, C.P.; Suvak, M.K.; Bux, D.A., Jr.; Oslin, D.; O’Brien, C.P.; Imms, P.; Riggs, D.S.; Volpicelli, J. Concurrent naltrexone and prolonged exposure therapy for patients with comorbid alcohol dependence and PTSD: A randomized clinical trial. JAMA 2013, 310, 488–495, doi:10.1001/jama.2013.8268.
25. Hamner, M.B.; Robert, S.; Frueh, B.C. Treatment-resistant posttraumatic stress disorder: Strategies for intervention. CNS Spectr. 2004, 9, 740–752.
26. Guy, W. Clinical Global Impressions. In ECDEU Assessment Manual for Psychopharmacology, Revised; US Department of Health, Education and Welfare, National Institute of Mental Health: Bethesda, MD, USA, 1976; pp. 217–222.
27. Foa, E.B.; Dancu, C.V.; Hembree, E.A.; Jaycox, L.H.; Meadows, E.A.; Street, G.P. A comparison of exposure therapy, stress inoculation training, and their combination for reducing posttraumatic stress disorder in female assault victims. J. Consult. Clin. Psychol. 1999, 67, 194–200, doi:10.1037/0022-006X.67.2.194.
28. Simon, G.E.; Rutter, C.M.; Stewart, C.; Pabiniak, C.; Wehnes, L. Response to past depression treatments is not accurately recalled: comparison of structured recall and patient health questionnaire scores in medical records. J. Clin. Psychiatry 2012, 73, 1503–1508, doi:10.4088/JCP.12m07883.
29. Desseilles, M.; Witte, J.; Chang, T.E.; Iovieno, N.; Dording, C.M.; Ashih, H.; Nyer, M.; Freeman, M.P.; Fava, M.; Mischoulon, D. Assessing the adequacy of past antidepressant trials: A clinician’s guide to the antidepressant treatment response questionnaire. J. Clin. Psychiatry 2011, 72, 1152–1154, doi:10.4088/JCP.11ac07225.
30. Ipser, J.C.; Stein, D.J. Evidence-based pharmacotherapy of post-traumatic stress disorder (PTSD). Int. J. Neuropsychopharmacol. 2012, 15, 825–840, doi:10.1017/S1461145711001209.
31. American Psychiatric Association (APA). Diagnostic and Statistical Manual of Mental Disorders, 5th ed.; APA: Arlington, MA, USA, 2013.
32. Williams, M.T.; Cahill, S.P.; Foa, E.B. Psychotherapy for posttraumatic stress disorder. In Textbook of Anxiety Disorders, 2nd ed.; Stein, D.J., Hollander, E., Rothbaum, B.O., Eds.; American Psychiatric Publishing: Arlington, MA, USA, 2009; pp. 603–628.
33. Lockwood, A.; Steinke, D.T.; Botts, S.R. Medication adherence and its effect on relapse among patients discharged from a Veterans Affairs posttraumatic stress disorder treatment program. Ann. Pharmacother. 2009, 43, 1227–1232, doi:10.1345/aph.1M017.
34. Bulloch, A.G.; Patten, S.B. Non-adherence with psychotropic medications in the general population. Soc. Psychiatry Psychiatr. Epidemiol. 2010, 45, 47–56, doi:10.1007/s00127-009-0041-5.
35. Osterberg, L.; Blaschke, T. Adherence to medication. N. Engl. J. Med. 2005, 353, 487–497, doi:10.1056/NEJMra050100.
36. Connor, K.M.; Sutherland, S.M.; Tupler, L.A.; Malik, M.L.; Davidson, J.R. Fluoxetine in post-traumatic stress disorder: Randomised, double-blind study. Br. J. Psychiatry 1999, 175, 17–22, doi:10.1192/bjp.175.1.17.
37. Martenyi, F.; Brown, E.B.; Zhang, H.; Prakash, A; Koke, S.C. Fluoxetine versus placebo in posttraumatic stress disorder. J. Clin. Psychiatry 2002, 63, 199–206, doi:10.4088/JCP.v63n0305.
38. Marshall, R.D.; Beebe, K.L.; Oldham, M.; Zaninelli, R. Efficacy and safety of paroxetine treatment for chronic PTSD: A fixed-dose, placebo-controlled study. Am. J. Psychiatry 2001, 158, 1982–1988, doi:10.1176/appi.ajp.158.12.1982.
39. Marshall, R.D.; Lewis‐Fernandez, R.; Blanco, C.; Simpson, H.B.; Lin, S.; Vermes, D.; Garcia, W.; Schneier, F.; Neria, Y.; Sanchez-Lacay, A.; et al. A controlled trial of paroxetine for chronic PTSD, dissociation, and interpersonal problems in mostly minority adults. Depress. Anxiety 2007, 24, 77–84, doi:10.1002/da.20176.
40. Tucker, P.; Zaninelli, R.; Yehuda, R.; Ruggiero, L.; Dillingham, K.; Pitts, C.D. Paroxetine in the treatment of chronic posttraumatic stress disorder: Results of a placebo-controlled, flexible-dosage trial. J. Clin. Psychiatry 2001, 62, 860–868, doi:10.4088/JCP.v62n1105.
41. Schneier, F.R.; Neria, Y.; Pavlicova, M.; Hembree, E.; Suh, E.J.; Amsel, L.; Marshall, R.D. Combined prolonged exposure therapy and paroxetine for PTSD related to the World Trade Center attack: A randomized controlled trial. Am. J. Psychiatry 2012, 169, 80–88, doi:10.1176/appi.ajp.2011.11020321.
42. Brady, K.; Pearlstein, T.; Asnis, G.M.; Baker, D.; Rothbaum, B.; Sikes, C.R.; Farfel, G.M. Efficacy and safety of sertraline treatment of posttraumatic stress disorder. JAMA 2000, 283, 1837–1844, doi:10.1001/jama.283.14.1837.
43. Panahi, Y.; Moghaddam, B.R.; Sahebkar, A.; Nazari, M.A.; Beiraghdar, F.; Karami, G.; Saadat, A.R. A randomized, double-blind, placebo-controlled trial on the efficacy and tolerability of sertraline in Iranian veterans with post-traumatic stress disorder. Psychol. Med. 2011, 41, 2159–2166, doi:10.1017/S0033291711000201.
44. Davidson, J.; Baldwin, D.; Stein, D.J.; Kuper, E.; Benattia, I.; Ahmed, S.; Pedersen, R.; Musgnung, J. Treatment of posttraumatic stress disorder with venlafaxine extended release: A 6-month randomized controlled trial. Arch. Gen. Psychiatry 2006, 63, 1158–1165.
45. Kosten, T.R.; Frank, J.B.; Dan, E.; McDougle, C.J.; Giller, E., Jr. Pharmacotherapy for posttraumatic stress disorder using phenelzine or imipramine. J. Nerv. Ment. Dis. 1991, 179, 366–370, doi:10.1097/00005053-199106000-00011.
46. Davis, L.L.; Jewell, M.E.; Ambrose, S.; Farley, J.; English, B.; Bartolucci, A.; Petty, F. A placebo-controlled study of nefazodone for the treatment of chronic posttraumatic stress disorder: A preliminary study. J. Clin. Psychopharmacol. 2004, 24, 291–297.
47. Bartzokis, G.L.; Po, H.; Turner, J.; Mintz, J.; Saunders, C.S. Adjunctive risperidone in the treatment of chronic combat-related posttraumatic stress disorder. Biol. Psychiatry 2005, 57, 474–479, doi:10.1016/j.biopsych.2004.11.039.
48. Raskind, M.A.; Peskind, E.R.; Kanter, E.D.; Petrie, E.C.; Radant, A.; Thompson, C.E.; Dobie, D.J.; Hoff, D.; Rein, R.J.; Straits-Troster, K.; et al. Reduction of nightmares and other PTSD symptoms in combat veterans by prazosin: A placebo controlled study. Am. J. Psychiatry 2003, 160, 371–373, doi:10.1176/appi.ajp.160.2.371.
49. Akuchekian, S.; Amanat, S. The comparison of topiramate and placebo in the treatment of posttraumatic stress disorder: A randomized, double-blind study. J. Res. Med. Sci. 2004, 9, 240–244.
50. Cloitre, M.; Koenen, K.C.; Cohen, L.R.; Han, H. Skills training in affective and interpersonal regulation followed by exposure: A phase-based treatment for PTSD related to childhood abuse. J. Consult. Clin. Psychol. 2002, 70, 1067–1074, doi:10.1037/0022-006X.70.5.1067.
51. Resick, P.A.; Nishith, P.; Weaver, T.L.; Astin, M.C.; Feuer, C.A. A comparison of cognitive-processing therapy with prolonged exposure and a waiting condition for the treatment of chronic posttraumatic stress disorder in female rape victims. J. Consult. Clin. Psychol. 2002, 70, 867–879, doi:10.1037/0022-006X.70.4.867.
52. Foa, E.B.; Hembree, E.A.; Cahill, S.P.; Rauch, S.A.M.; Riggs, D.S.; Feeny, N.C.; Yadin, E. Randomized trial of prolonged exposure for posttraumatic stress disorder with and without cognitive restructuring: Outcome at academic and community clinics. J. Consult. Clin. Psychol. 2005, 73, 953–964, doi: 10.1037/0022-006X.73.5.953.
53. Rothbaum, B.O.; Astin, M.C.; Marsteller, F. Prolonged exposure versus eye movement desensitization and reprocessing (EMDR) for PTSD rape victims. J. Trauma. Stress 2005, 18, 607–616, doi:10.1002/jts.20069.
54. Schnurr, P.P.; Friedman, M.J.; Engel, C.C.; Foa, E.B.; Shea, T.; Chow, B.K.; Resick, P.A.; Thurston, V.; Orsillo, S.M.; Haug, R.; et al. Cognitive behavioral therapy for posttraumatic stress disorder in women. JAMA 2007, 297, 820–830, doi:10.1001/jama.297.8.820.
55. Mills, K.L.; Teesson, M.; Back, S.E.; Brady, K.T.; Baker, A.L.; Hopwood, S.; Sannibale, C.; Barrett, E.L.; Merz, S.; Rosenfeld, J.; et al. Integrated exposure-based therapy for co-occurring posttraumatic stress disorder and substance dependence: A randomized controlled trial: Exposure therapy for PTSD and substance dependence. JAMA 2012, 308, 690–699.
56. Pacella, M.L.; Armelie, A.; Boarts, J.; Wagner, G.; Jones, T.; Feeny, N.; Delahanty, D.L. The impact of prolonged exposure on PTSD symptoms and associated psychopathology in people living with HIV: A randomized test of concept. AIDS Behav. 2012, 16, 1327–1340.
57. Chard, K.M. An evaluation of cognitive processing therapy for the treatment of posttraumatic stress disorder related to childhood sexual abuse. J. Consult. Clin. Psychol. 2005, 73, 965–971, doi:10.1037/0022-006X.73.5.965.
58. Monson, C.M.; Schnurr, P.P.; Resick, P.A.; Friedman, M.J.; Young-Xu, Y.; Stevens, S.P. Cognitive processing therapy for veterans with military-related posttraumatic stress disorder. J. Consult. Clin. Psychol. 2006, 74, 898–907, doi:10.1037/0022-006X.74.5.898.
59. Forbes, D.; Lloyd, D.; Nixon, R.D.V.; Elliott, P.; Varker, T.; Perry, D.; Bryant, R.A.; Creamer, M. A multisite randomized controlled effectiveness trial of cognitive processing therapy for military-related posttraumatic stress disorder. J. Anxiety Disord. 2012, 26, 442–452.
60. Ehlers, A.; Clark, D.M.; Hackmann, A.; McManus, F.; Fennell, M.; Herbert, C.; Mayou, R. A randomized controlled trial of cognitive therapy, a self-help booklet, and repeated assessments as early interventions for posttraumatic stress disorder. Arch. Gen. Psychiatry 2003, 60, 1024–1032, doi:10.1001/archpsyc.60.10.1024.
61. Kubany, E.S.; Hill, E.E.; Owens, J.A. Cognitive trauma therapy for battered women with PTSD: Preliminary findings. J. Trauma. Stress 2003, 16, 81–91, doi:10.1023/A:1022019629803.
62. Kubany, E.S.; Hill, E.E.; Owens, J.A.; Iannce-Spencer, C.; McCaig, M.A.; Tremayne, K.J.; Williams, P.L. Cognitive trauma therapy for battered women with PTSD (CTT-BW). J. Consult. Clin. Psychol. 2004, 72, 3–18, doi:10.1037/0022-006X.72.1.3.
63. Duffy, M.; Gillespie, K.; Clark, D.M. Post-traumatic stress disorder in the context of terrorism and other civil conflict in Northern Ireland: randomised controlled trial. Br. Med. J. 2007, 334, 1147–1150, doi: 10.1136/bmj.39021.846852.BE.
64. Hollifield, M.; Sinclair-Lian, N.; Warner, T.D.; Hammerschlag, R. Acupuncture for posttraumatic stress disorder: A randomized controlled pilot trial. J. Nerv. Ment. Dis. 2007, 195, 504–513, doi:10.1097/NMD.0b013e31803044f8.
65. Cottraux, J.; Note, I.; Yao, S.N.; de Mey-Guillard, C.; Bonasse, F.; Djamoussian, D.; Mollard, E.; Note, B.; Chen, Y. Randomized controlled comparison of cognitive behavior therapy with Rogerian supportive therapy in chronic post-traumatic stress disorder: A 2-year follow-up. Psychother. Psychosom. 2008, 77, 101–110, doi:10.1159/000112887.
66. Mueser, K.T.; Rosenberg, S.D.; Xie, H.; Jankowski, M.K.; Bolton, E.E.; Lu, W.; Hamblen, J.L.; Rosenberg, H.J.; McHugo, G.J.; Wolfe, R. A randomized controlled trial of cognitive-behavioral treatment for posttraumatic stress disorder in severe mental illness. J. Consult. Clin. Psychol. 2008, 76, 259–271, doi:10.1037/0022-006X.76.2.259.
67. Knaevelsrud, C.; Maercker, A. Internet-based treatment for PTSD reduces distress and facilitates the development of a strong therapeutic alliance: A randomized controlled clinical trial. BMC Psychiatry 2007, 7, doi:10.1186/1471-244X-7-13.
68. Litz, B.; Engel, C.; Bryant, R.; Papa, A. A randomized, controlled proof-of-concept trial of an Internet-based, therapist-assisted self-management treatment for posttraumatic stress disorder. Am. J. Psychiatry 2007, 164, 1676–1684, doi:10.1176/appi.ajp.2007.06122057.
69. Spence, J.; Titov, N.; Dear, B.F.; Johnston, L.; Solley, K.; Lorian, C.; Wootton, B.; Zou, J.; Schwenke, G. Randomized controlled trial of Internet‐delivered cognitive behavioral therapy for posttraumatic stress disorder. Depress. Anxiety 2011, 28, 541–550, doi:10.1002/da.20835.
70. Krupnick, J.L.; Green, B.L.; Stockton, P.; Miranda, J.; Krause, E.; Mete, M. Group interpersonal psychotherapy for low-income women with posttraumatic stress disorder. Psychother. Res. 2008, 18, 497–507, doi:10.1080/10503300802183678.
71. Monson, C.M.; Fredman, S.J.; Macdonald, A.; Pukay-Martin, N.D.; Resick, P.A.; Schnurr, P.P. Effect of cognitive-behavioral couple therapy for PTSD: A randomized controlled trial: Cognitive-behavioral couple therapy for PTSD. JAMA 2012, 308, 700–709.
72. Niles, B.L.; Klunk-Gillis, J.; Ryngala, D.J.; Silberbogen, A.K.; Paysnick, A.; Wolf, E.J. Comparing mindfulness and psychoeducation treatments for combat-related PTSD using a telehealth approach. Psychol. Trauma 2012, 4, 538–547, doi:10.1037/a0026161.
73. Jain, S.; McMahon, G.F.; Hasen, P.; Kozub, M.P.; Porter, V.; King, R.; Guarneri, E.M. Healing Touch with Guided Imagery for PTSD in returning active duty military: A randomized controlled trial. Mil. Med. 2012, 177, 1015–1021, doi:10.7205/MILMED-D-11-00290.
74. Kent, M.; Davis, M.C.; Stark, S.L.; Stewart, L.A. A resilience‐oriented treatment for posttraumatic stress disorder: Results of a preliminary randomized clinical trial. J. Trauma. Stress 2011, 24, 591–595, doi:10.1002/jts.20685.
75. Church, D.; Hawk, C.; Brooks, A.J.; Toukolehto, O.; Wren, M.; Dinter, I.; Stein, P. Psychological trauma symptom improvement in veterans using Emotional Freedom Techniques: A randomized controlled trial. J. Nerv. Ment. Dis. 2013, 201, 153–160, doi:10.1097/NMD.0b013e31827f6351.
76. Nakamura, Y.; Lipschitz, D.L.; Landward, R.; Kuhn, R.; West, G. Two sessions of sleep-focused mind–body bridging improve self-reported symptoms of sleep and PTSD in veterans: A pilot randomized controlled trial. J. Psychosom. Res. 2011, 70, 335–345.
77. Zhang, Y.; Feng, B.; Xie, J.; Xu, F.; Chen, J. Clinical study on treatment of the earthquake-caused post-traumatic stress disorder by cognitive-behavior therapy and acupoint stimulation. J. Tradit. Chin. Med. 2011, 31, 60–63, doi:10.1016/S0254-6272(11)60014-9.